Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

6-(m-Amidinophenyldiazoamino)-4-amino-1,2-dimethylquinazolinium Chloride Hydrochloride : a New Drug active against Babesia canis

Abstract

As part of a study of diamidines which has extended over many years, we have recently screened for trypanocidal and babesicidal activity a number of compounds in which one of the amidine groups has been replaced by a cyclic amidine group. One of the most active of these is 6-(m-amidinophenyldiazoamino)-4-amino-1,2-dimethylquinazolinium chloride hydrochloride1 : (M. and B. 4986) (I). This compound, which contains the m-amidinophenyldiazoamino linkage present in the very active trypanocidal drug, isometamidium2, has babesicidal properties and is markedly active against Babesia canis in dogs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. May and Baker, Ltd., and Berg, S. S., Brit. Pat. App. 19267/58.

  2. Berg, S. S., Nature, 188, 1106 (1960).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BERG, S., LUCAS, J. 6-(m-Amidinophenyldiazoamino)-4-amino-1,2-dimethylquinazolinium Chloride Hydrochloride : a New Drug active against Babesia canis. Nature 189, 64 (1961). https://doi.org/10.1038/189064a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/189064a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing